Antiplatelet Therapy for Silent Brain Infarction "ANTISBI"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Silent brain infarction (SBI) or incidental infarct is common. Recent studies revealed individuals with SBI have an increased risk of future stroke. Even though the 2014 AHA/ASA recommendation for ischemic stroke and transient ischemic attack considered SBI as an entry point for secondary prevention, convincing evidence with regard to the preventive efficacy of antiplatelet therapy against incident stroke in SBI...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 October 2017.

1 Jan 2018 19 Oct 2017 1 Jul 2021 1 Dec 2021 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

Not available